This site is intended for healthcare professionals
News

CHMP recommends Aybintio, a bevacizumab biosimilar.-Samsung Bioepis + Merck Inc.

Read time: 1 mins
Last updated:29th Jun 2020
Published:28th Jun 2020
Condition: Non Small Cell Lung Cancer
Type: drug
Register free for full access to medthority.com